Become a member
bannière biohub 2100x452

Welcome to the MabDesign Bio-hub

On the MabDesign Bio-Hub, you’ll find a wealth of information on the biopharmaceutical sector: thematic market analyses, explanatory articles on biopharmaceuticals, biomanufacturing and all that goes with it, as well as our famous immunowatches and bioprocess watches.

As an association representing the biomedical industry, part of our mission is to put our expertise at the service of innovation and the companies behind it. If you haven’t heard of MabDesign yet, we invite you to take a look at our about us page to find out more !

All themes
Tags
conjugués anticorps-oligonucléotides, antibody oligonucleotides conjugates

Antibody-oligonucleotides conjugates

Each month, MabDesign's market analyses give you an overview of market dynamics and projects in development for a given indication or technology, to help you better understand the constantly evolving market for biomedicines and biomanufacturing. This month, an overview of antibody-oligonucleotide conjugate (AOC) projects currently in development.
Cell therapies, interview, expert's corner

Experts’ corner : Cell therapies

The Experts Corner - Read our interview with Sophie Derenne from the EFS, on the cell therapy market, its challenges and prospects.
thérapies géniques

Gene therapies

This month's MabDesign market analysis gives you an overview of the gene therapy market and projects currently in development.
vecteurs viraux, AAV, adénovirus

Bioproduction of viral vectors: challenges, innovations and market prospects

Viral vectors are essential therapeutic tools for gene therapy and certain vaccines. The growing number of cell and gene therapy products on the market means that the production of viral vectors is an increasingly strategic sector.

Respiratory syncitial virus

This month's MabDesign market analysis gives you an overview of market dynamics and projects in development targeting respiratory syncitial virus (RSV).
Bioproduction

Biomanufacturing of biological drugs: strategic issues and challenges

Biomanufacturing, or the manufacturing phase of innovative biological medicines, is a rapidly expanding field that is essential for meeting modern healthcare needs and represents a major strategic challenge. Faced with growing dependence on imports and increasing international competition, there are many technological and industrial challenges to developing this sector. In France, major efforts are being made, notably through the France 2030 plan, to ensure pharmaceutical sovereignty and meet future medical needs. This article explores the challenges and opportunities presented by biomanufacturing.
maladies infectieuses, pipeline, marché,

Infectious diseases

This month, MabDesign's market analysis gives you an overview of projects in development in the field of infectious diseases.
marché cancer du sein, cancer du sein, analyse marché

breast cancer

The MabDesign market analysis for this month of pink October gives you an overview of market dynamics and projects in development targeting the treatment of breast cancer.
Marché sclérose en plaques

Multiple Sclerosis

This month's MabDesign market analysis gives you an overview of market dynamics and development projects targeting the treatment of multiple sclerosis.

SUBSCRIBE TO OUR NEWSLETTER

Become a member
Contact

Follow us

© MabDesign – Legal Notice – Cookies – Design by IGTech